Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bally

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Vaccines|April 23, 2025
Pre-Existing Anti-Vector Immunity to Adenovirus-Inspired VLP Vaccines Shows an Adjuvant-Dependent AntagonismSalomé Gallet, Dalil Hannani, Sebastian Dergan-Dylon, et al.
ACS Nano|January 11, 2011
Proteins of the innate immune system crystallize on carbon nanotubes but are not activatedWai Li Ling, Adrienn Biro, Isabelle Bally, et al.
Frontiers in Immunology|January 11, 2020
Two Different Missense <i>C1S</i> Mutations, Associated to Periodontal Ehlers-Danlos Syndrome, Lead to Identical Molecular OutcomesIsabelle Bally, Fabien Dalonneau, Anne Chouquet, et al.
The FEBS Journal|November 2, 2025
The fc fragment of IgMs binds C1q to activate the first step of the classical complement pathway, while inhibiting complement-dependent cytotoxicityAndrea J Pinto, Anne Chouquet, Isabelle Bally, et al.
Frontiers in Immunology|May 14, 2023
HMGB1 cleavage by complement C1s and its potent anti-inflammatory productMarie Lorvellec, Anne Chouquet, Jonas Koch, et al.
Scientific Reports|July 22, 2021
Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometryAlessandra Luchini, Samantha Micciulla, Giacomo Corucci, et al.
Frontiers in Immunology|November 16, 2020
Complement C1q Interacts With LRP1 Clusters II and IV Through a Site Close but Different From the Binding Site of Its C1r and C1s-Associated ProteasesGuillaume Fouët, Evelyne Gout, Catherine Wicker-Planquart, et al.
Frontiers in Immunology|November 22, 2019
<i>C1R</i> Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos SyndromeRebekka Gröbner, Ines Kapferer-Seebacher, Albert Amberger, et al.
Frontiers in Immunology|December 28, 2019
Corrigendum: <i>C1R</i> Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos SyndromeRebekka Gröbner, Ines Kapferer-Seebacher, Albert Amberger, et al.
Plos Pathogens|May 20, 2021
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonistMichel Thépaut, Joanna Luczkowiak, Corinne Vivès, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Vaccines|April 23, 2025
Pre-Existing Anti-Vector Immunity to Adenovirus-Inspired VLP Vaccines Shows an Adjuvant-Dependent AntagonismSalomé Gallet, Dalil Hannani, Sebastian Dergan-Dylon, et al.
ACS Nano|January 11, 2011
Proteins of the innate immune system crystallize on carbon nanotubes but are not activatedWai Li Ling, Adrienn Biro, Isabelle Bally, et al.
Frontiers in Immunology|January 11, 2020
Two Different Missense <i>C1S</i> Mutations, Associated to Periodontal Ehlers-Danlos Syndrome, Lead to Identical Molecular OutcomesIsabelle Bally, Fabien Dalonneau, Anne Chouquet, et al.
The FEBS Journal|November 2, 2025
The fc fragment of IgMs binds C1q to activate the first step of the classical complement pathway, while inhibiting complement-dependent cytotoxicityAndrea J Pinto, Anne Chouquet, Isabelle Bally, et al.
Frontiers in Immunology|May 14, 2023
HMGB1 cleavage by complement C1s and its potent anti-inflammatory productMarie Lorvellec, Anne Chouquet, Jonas Koch, et al.
Scientific Reports|July 22, 2021
Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometryAlessandra Luchini, Samantha Micciulla, Giacomo Corucci, et al.
Frontiers in Immunology|November 16, 2020
Complement C1q Interacts With LRP1 Clusters II and IV Through a Site Close but Different From the Binding Site of Its C1r and C1s-Associated ProteasesGuillaume Fouët, Evelyne Gout, Catherine Wicker-Planquart, et al.
Frontiers in Immunology|November 22, 2019
<i>C1R</i> Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos SyndromeRebekka Gröbner, Ines Kapferer-Seebacher, Albert Amberger, et al.
Frontiers in Immunology|December 28, 2019
Corrigendum: <i>C1R</i> Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos SyndromeRebekka Gröbner, Ines Kapferer-Seebacher, Albert Amberger, et al.
Plos Pathogens|May 20, 2021
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonistMichel Thépaut, Joanna Luczkowiak, Corinne Vivès, et al.
Pageof 4